Approval · Notice of Compliance 1092 · 2000
DDAVP: Notice of Compliance 1092
Issued September 14, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1092
- Date
- September 14, 2000
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: for the treatment of nocturnal enuresis
- Therapeutic class
- Antidiuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DDAVP | Not yet assigned | — |
Medicinal ingredients
- DESMOPRESSIN ACETATE 0.1 MG per TAB
- DESMOPRESSIN ACETATE 0.2 MG per TAB